...
首页> 外文期刊>Nature >Unexpected link between an antibiotic, pannexin channels and apoptosis
【24h】

Unexpected link between an antibiotic, pannexin channels and apoptosis

机译:抗生素,pannexin通道与细胞凋亡之间的意外关联

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

凋亡细胞的胞质膜上的Pamexin 1通道介导"find-me"分子信号的释放,这种信号吸引吞噬细胞,后者的任务是清除死亡的细胞。在对小分子所做的一项无偏筛选中,Kodi Ravichandran及同事发现喹诺酮抗体Trova-floxacin是Pannexin 1通道活性的一种直接抑制分子,导致凋亡细胞的失控碎片化。这项工作确定了Pannexin通道在凋亡细胞的有序分解中扮演一个必要角色,同时还可能重新激发人们对与Pannexin 1通道没有交叉反应的喹诺酮抗体的兴趣,这种交叉反应也许可解释在Trova-floxacin的临床试验中所出现的特别毒性。%Plasma membrane pannexin 1 channels (PANX1) release nucleotide find me signals from apoptotic cells to attract phagocytes. Here we show that the quinolone antibiotic trovafloxacin is a novel PANX1 inhibitor, by using a small-molecule screen. Although quinolones are widely used to treat bacterial infections, some quinolones have unexplained side effects, including deaths among children. PANX1 is a direct target of trovafloxacin at drug concentrations seen in human plasma, and its inhibition led to dysregulated fragmentation of apoptotic cells. Genetic loss of PANX1 phenocopied trovafloxacin effects, revealing a non-redundant role for pannexin channels in regulating cellular disassembly during apoptosis. Increase in drug-resistant bacteria worldwide and the dearth of new antibiotics is a major human health challenge. Comparing different quinolone antibiotics suggests that certain structural features may contribute to PANX1 blockade. These data identify a novel linkage between an antibiotic, pannexin channels and cellular integrity, and suggest that re-engineering certain quinolones might help develop newer antibacterials.
机译:凋亡细胞的胞质膜上的Pamexin 1通道介导"find-me"分子信号的释放,这种信号吸引吞噬细胞,后者的任务是清除死亡的细胞。在对小分子所做的一项无偏筛选中,Kodi Ravichandran及同事发现喹诺酮抗体Trova-floxacin是Pannexin 1通道活性的一种直接抑制分子,导致凋亡细胞的失控碎片化。这项工作确定了Pannexin通道在凋亡细胞的有序分解中扮演一个必要角色,同时还可能重新激发人们对与Pannexin 1通道没有交叉反应的喹诺酮抗体的兴趣,这种交叉反应也许可解释在Trova-floxacin的临床试验中所出现的特别毒性。%Plasma membrane pannexin 1 channels (PANX1) release nucleotide find me signals from apoptotic cells to attract phagocytes. Here we show that the quinolone antibiotic trovafloxacin is a novel PANX1 inhibitor, by using a small-molecule screen. Although quinolones are widely used to treat bacterial infections, some quinolones have unexplained side effects, including deaths among children. PANX1 is a direct target of trovafloxacin at drug concentrations seen in human plasma, and its inhibition led to dysregulated fragmentation of apoptotic cells. Genetic loss of PANX1 phenocopied trovafloxacin effects, revealing a non-redundant role for pannexin channels in regulating cellular disassembly during apoptosis. Increase in drug-resistant bacteria worldwide and the dearth of new antibiotics is a major human health challenge. Comparing different quinolone antibiotics suggests that certain structural features may contribute to PANX1 blockade. These data identify a novel linkage between an antibiotic, pannexin channels and cellular integrity, and suggest that re-engineering certain quinolones might help develop newer antibacterials.

著录项

  • 来源
    《Nature》 |2014年第7492期|329-334b1|共7页
  • 作者单位

    The Center tor Cell Clearance, University of Virginia, Charlottesville, Virginia 22908, USA,Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia 22908, USA,Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia 22908, USA,La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria 3086, Australia;

    Department of Pharmacology, University of Virginia, Charlottesville, Virginia 22908, USA;

    The Center tor Cell Clearance, University of Virginia, Charlottesville, Virginia 22908, USA,Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia 22908, USA,Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia 22908, USA;

    The Center tor Cell Clearance, University of Virginia, Charlottesville, Virginia 22908, USA,Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia 22908, USA,Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia 22908, USA;

    The Center tor Cell Clearance, University of Virginia, Charlottesville, Virginia 22908, USA,Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia 22908, USA,Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia 22908, USA;

    Department of Pharmacology, University of Virginia, Charlottesville, Virginia 22908, USA;

    The Center tor Cell Clearance, University of Virginia, Charlottesville, Virginia 22908, USA,Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia 22908, USA,Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia 22908, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号